To identify carriers of single heterozygous mutations in DOK7 (i.e., without a second rare variant within coding regions and exon-intron boundaries), we interrogated our database of clinically diagnosed CMS cases referred to us in the years 1996–2015. This evidence concerns the gene DOK7 and congenital myasthenic syndrome.